IL6 and chronic obstructive pulmonary disease: Epidemiological studies have reported that an increase in the levels of systemic inflammatory markers, mainly C-reactive protein (CRP), interleukin 6 (IL-6), and fibrinogen, predicts poor outcomes in COPD, higher propensity to infective exacerbations, and higher mortality [37–39].